SIBN
Price
$18.47
Change
+$0.04 (+0.22%)
Updated
Jul 3 closing price
Capitalization
672.23M
36 days until earnings call
TNDM
Price
$17.08
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
2.32B
31 days until earnings call
Interact to see
Advertisement

SIBN vs TNDM

Header iconSIBN vs TNDM Comparison
Open Charts SIBN vs TNDMBanner chart's image
SI-BONE
Price$18.47
Change+$0.04 (+0.22%)
Volume$288.62K
Capitalization672.23M
Tandem Diabetes Care
Price$17.08
Change-$0.00 (-0.00%)
Volume$163
Capitalization2.32B
SIBN vs TNDM Comparison Chart in %
Loading...
SIBN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNDM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SIBN vs. TNDM commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SIBN is a StrongBuy and TNDM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (SIBN: $18.47 vs. TNDM: $17.08)
Brand notoriety: SIBN and TNDM are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: SIBN: 53% vs. TNDM: 0%
Market capitalization -- SIBN: $672.23M vs. TNDM: $2.32B
SIBN [@Medical Specialties] is valued at $672.23M. TNDM’s [@Medical Specialties] market capitalization is $2.32B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SIBN’s FA Score shows that 0 FA rating(s) are green whileTNDM’s FA Score has 0 green FA rating(s).

  • SIBN’s FA Score: 0 green, 5 red.
  • TNDM’s FA Score: 0 green, 5 red.
According to our system of comparison, SIBN is a better buy in the long-term than TNDM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SIBN’s TA Score shows that 6 TA indicator(s) are bullish while TNDM’s TA Score has 4 bullish TA indicator(s).

  • SIBN’s TA Score: 6 bullish, 3 bearish.
  • TNDM’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, SIBN is a better buy in the short-term than TNDM.

Price Growth

SIBN (@Medical Specialties) experienced а +2.10% price change this week, while TNDM (@Medical Specialties) price change was -10.62% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.93%. For the same industry, the average monthly price growth was +1.81%, and the average quarterly price growth was -0.17%.

Reported Earning Dates

SIBN is expected to report earnings on Nov 10, 2025.

TNDM is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Medical Specialties (+1.93% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TNDM($2.32B) has a higher market cap than SIBN($672M). SIBN YTD gains are higher at: 31.740 vs. TNDM (-52.582). SIBN has higher annual earnings (EBITDA): -34.45M vs. TNDM (-196.97M). TNDM has more cash in the bank: 468M vs. SIBN (166M). SIBN has less debt than TNDM: SIBN (39M) vs TNDM (416M). TNDM has higher revenues than SIBN: TNDM (748M) vs SIBN (139M).
SIBNTNDMSIBN / TNDM
Capitalization672M2.32B29%
EBITDA-34.45M-196.97M17%
Gain YTD31.740-52.582-60%
P/E RatioN/A666.67-
Revenue139M748M19%
Total Cash166M468M35%
Total Debt39M416M9%
FUNDAMENTALS RATINGS
SIBN vs TNDM: Fundamental Ratings
SIBN
TNDM
OUTLOOK RATING
1..100
2353
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
99
Overvalued
PROFIT vs RISK RATING
1..100
97100
SMR RATING
1..100
9398
PRICE GROWTH RATING
1..100
4365
P/E GROWTH RATING
1..100
10094
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SIBN's Valuation (44) in the Medical Specialties industry is somewhat better than the same rating for TNDM (99). This means that SIBN’s stock grew somewhat faster than TNDM’s over the last 12 months.

SIBN's Profit vs Risk Rating (97) in the Medical Specialties industry is in the same range as TNDM (100). This means that SIBN’s stock grew similarly to TNDM’s over the last 12 months.

SIBN's SMR Rating (93) in the Medical Specialties industry is in the same range as TNDM (98). This means that SIBN’s stock grew similarly to TNDM’s over the last 12 months.

SIBN's Price Growth Rating (43) in the Medical Specialties industry is in the same range as TNDM (65). This means that SIBN’s stock grew similarly to TNDM’s over the last 12 months.

TNDM's P/E Growth Rating (94) in the Medical Specialties industry is in the same range as SIBN (100). This means that TNDM’s stock grew similarly to SIBN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SIBNTNDM
RSI
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
80%
Bullish Trend 4 days ago
72%
Momentum
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
83%
MACD
ODDS (%)
Bullish Trend 4 days ago
76%
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 4 days ago
82%
Advances
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 19 days ago
78%
Declines
ODDS (%)
Bearish Trend 14 days ago
79%
Bearish Trend 4 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
76%
Aroon
ODDS (%)
Bearish Trend 4 days ago
78%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
SIBN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNDM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LMOIX41.400.45
+1.10%
ClearBridge Small Cap Growth IS
VFAIX64.990.69
+1.07%
Vanguard Financials Index Admiral
ISTAX25.790.20
+0.78%
ICON Equity Investor
TGRGX7.440.01
+0.13%
Transamerica International Focus I
JARSX15.750.01
+0.06%
Easterly Global Real Estate R6

TNDM and

Correlation & Price change

A.I.dvisor indicates that over the last year, TNDM has been loosely correlated with TFX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if TNDM jumps, then TFX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNDM
1D Price
Change %
TNDM100%
N/A
TFX - TNDM
44%
Loosely correlated
-1.39%
CLPT - TNDM
40%
Loosely correlated
+3.63%
SHC - TNDM
38%
Loosely correlated
+0.90%
AZTA - TNDM
37%
Loosely correlated
+1.16%
A - TNDM
37%
Loosely correlated
+0.60%
More